| Trial ID: | L0815 |
| Source ID: | IRCT2017080135408N1
|
| Associated Drug: |
Probiotic
|
| Title: |
The influence of probiotics and Zinc on the serum levels of liver enzymes and lipid profile in patients with non-alcoholic fatty liver disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-alcoholic fatty liver disease. <br>K76.0
|
| Interventions: |
Intervention 1: Two protexin probiotic capsules 600 mg (Probiotics international, United Kingdom) and two zinc sulfate capsules 25 mg (Alhavi, Iran)are used daily, at noon and at night after meals, for three months.<br>The protexin capsule contains 7 spe
|
| Outcome Measures: |
ALT. Timepoint: Before and 3 months after intervention. Method of measurement: Blood test.;AST. Timepoint: Before and 3 months after intervention. Method of measurement: Blood test.;FBS. Timepoint: Before and 3 months after intervention. Method of measurement: Blood test.;Total cholesterol. Timepoint: Before and 3 months after intervention. Method of measurement: Blood test.;Triglyceride. Timepoint: Before and 3 months after intervention. Method of measurement: Blood test.;HDL. Timepoint: Before and 3 months after intervention. Method of measurement: Blood test.;LDL. Timepoint: Before and 3 months after intervention. Method of measurement: Blood test.;CRP. Timepoint: Before and 3 months after intervention. Method of measurement: Blood test.Weight. Timepoint: Before and 3 months after intervention. Method of measurement: Scale.;Body mass index (BMI). Timepoint: Before and 3 months after intervention. Method of measurement: Body mass is expressed in units of kg/m2.;Waist. Timepoint: Before and 3 months after intervention. Method of measurement: Centimeter.
|
| Sponsor/Collaborators: |
Research Center for Infectious Diseases of the Digestive System, Vice Chancellor research of Ahvaz J
|
| Gender: |
All
|
| Age: |
18 years90 years
|
| Phases: |
Not applicable
|
| Enrollment: |
128
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment.
|
| Start Date: |
12/08/2017
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
22 February 2018
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/26762
|
